Last edition
News about "SARS-CoV-2 "
European Commission Approves Pfizer-BioNTech's XFG-Adapted COVID-19 Vaccine for 2026-27 Season
The European Commission has approved Pfizer and BioNTech's monovalent XFG-adapted COVID-19 vaccine for the 2026–27 vaccination season that authorised for people aged six months and above, is designed to enhance protection against currently circulating SARS-CoV-2 variants and will be supplied across the European Union and selected European countries.
SARS-CoV-2. | 31/07/2026 | By News Bureau
ICMR, CDSCO Invite Public Comments on Draft Evaluation Protocols for In-Vitro Diagnostics
The Indian Council of Medical Research (ICMR), in collaboration with the Central Drugs Standard Control Organisation (CDSCO), has released draft standard evaluation protocols for the performance evaluation of In-Vitro Diagnostics (IVDs) for use by IVD manufacturers and testing labs in India.
SARS-CoV-2 | 12/08/2025 | By Dineshwori | 298
Pfizer and BioNTech's Updated COVID-19 Vaccine Secures EMA Nod, Awaits Final EU Approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Pfizer- BioNTech's LP.8.1-adapted monovalent COVID-19 vaccine in the European Union.
SARS-CoV-2 | 28/07/2025 | By Dineshwori | 291
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy